Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
Recruiting · NCT07110246 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas | low grade glioma | Recruiting | Phase 2 | 2026-09-03 | NCT07110246 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Rising Tide Foundation | 18 |
| University of California, San Francisco | 637 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's National Hospital | Washington D.C. | United States | 100 |
| Duke University Medical Center | Durham | United States | 505 |
| John Hopkins Medical Center | Baltimore | United States | 3 |
| Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center | Hackensack | United States | 3 |
| Riley Hospital for Children at Indiana University Health | Indianapolis | United States | 17 |
| St. Jude Children's Research Hospital | Memphis | United States | 194 |
| St. Louis Children's Hospital Washington University in St. Louis | St Louis | United States | 1 |
| University of Alabama at Birmingham | Birmingham | United States | 193 |
| University of California, San Francisco | San Francisco | United States | 294 |
| University of Utah | Salt Lake City | United States | 137 |